Novel Truncating Variants in PODXL Represent a New Entity to Be Explored Among Podocytopathies
García-Aznar, J.M. (Clinical Area of Genetic Diagnostic in Nephrology. Healthincode)
Besada-Cerecedo, M.L. (Clinical Area of Genetic Diagnostic in Nephrology. Healthincode)
Castro-Alonso, Cristina (Fundación para la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO))
Sierra Carpio, M. (Hospital Universitario San Pedro)
Blasco, M. (Hospital Clínic i Provincial de Barcelona)
Quiroga, Borja (Hospital Universitario de la Princesa (Madrid))
Červienka, M. (Hospital El Bierzo)
Mouzo, R. (Hospital El Bierzo)
Torra Balcells, Roser (Institut de Recerca Sant Pau)
Ortiz, Alberto (Universidad Autónoma de Madrid)
de Sequera, P. (Universidad Complutense de Madrid)
Universitat Autònoma de Barcelona

Date:	2025
Abstract:	Background/Objectives: Podocalyxin is a sialoprotein mainly expressed in the kidney cortex and lung tissue, which has been described as a component of the podocyte glycocalyx. This protein promotes the reorganization of the podocyte cytoskeleton, as well as the morphogenesis and differentiation of nascent podocytes, actively participating in glomerular filtration. Previous research has suggested that PODXL haploinsufficiency leads to podocytopathy with development of focal segmental glomerulosclerosis, a disorder that has been demonstrated in Podxl-deficient animal models and proposed as a primary cause in human families affected by this condition. However, only a few families have been reported, which limits the understanding about the spectrum of phenotype and prognosis of the disease. Methods: We performed high-throughput sequencing in a cohort of young adults with CKD, describing the clinical scenario of those who harbored truncating variants in the PODXL gene and testing the families for detected variants. Results: The PODXL gene exhibited a slight deviation in loss intolerance probability and moderate deviation in the observed/expected ratio of variation, which is typically observed in dominant genes with age-dependent incomplete penetrance or variable expression. We reported four novel truncating variants in the PODXL gene, along with a collection of previously published monoallelic truncating variants. Conclusions: These findings further support evidence about genetic defects in the PODXL gene associated with a new molecular entity of podocytopathy with adult onset. Additionally, the nucleotide sequence of PODXL contains particularities that require careful analysis to interpret the effect of the variants detected in this gene.
Rights:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Language:	Anglès
Document:	Article ; recerca ; Versió publicada
Subject:	CKD 1 ; PODXL 2 ; Podocytopathy 3
Published in:	Genes, Vol. 16 Núm. 4 (april 2025) , p. 464, ISSN 2073-4425

DOI: 10.3390/genes16040464
PMID: 40282423

13 p, 1.7 MB

The record appears in these collections:
Research literature > UAB research groups literature > Research Centres and Groups (research output) > Health sciences and biosciences > Institut de Recerca Sant Pau
Articles > Research articles
Articles > Published articles